Melanie E Royce (Melanie Royce)

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 9

Top Topics

Postoperative Pain

Ankylosing Spondylitis

Early Breast Cancer

Drug Administration

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Melanie E Royce, Flora Mulkey, Christy Osgood, Erik W Bloomquist, Laleh Amiri-Kordestani
US Food and Drug Administration Expanded Adjuvant Indication of Abemaciclib in High-Risk Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Melanie E Royce, Christy L Osgood, Anup K Amatya, Mallorie H Fiero, C J George Chang, Tiffany K Ricks, Krithika A Shetty, Jeffrey Kraft, Junshan Qiu, Pengfei Song, Rosane Charlab, Jingyu Yu, Kathryn E King, Anshu Rastogi, Brian Janelsins, Wendy C Weinberg, Kathleen Clouse, Vicky Borders-Hemphill, Lindsey Brown, Candace Gomez-Broughton, Zhong Li, Thuy Thanh Nguyen, Zhihao Qiu, Anh-Thy Ly, Suyoung Chang, Tingting Gao, Chi-Ming Tu, Bellinda King-Kallimanis, William F Pierce, Kelly Chiang, Clara Lee, Kirsten B Goldberg, John K Leighton, Shenghui Tang, Richard Pazdur, Julia A Beaver, Laleh Amiri-Kordestani
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (8) (2022)
Melanie E Royce, Christy Osgood, Flora Mulkey, Erik Bloomquist, William F Pierce, Arpita Roy, Shyam Kalavar, Soma Ghosh, Reena Philip, Fatima Rizvi, Bronwyn D Mixter, Shenghui Tang, Richard Pazdur, Julia A Beaver, Laleh Amiri-Kordestani
FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (11) (2022)
Shaily Arora, Preeti Narayan, Christy L Osgood, Suparna Wedam, Tatiana M Prowell, Jennifer J Gao, Mirat Shah, Danielle Krol, Sakar Wahby, Melanie E Royce, Soma Ghosh, Reena Philip, Gwynn Ison, Tara Berman, Christina Brus, Erik W Bloomquist, Mallorie H Fiero, Shenghui Tang, Richard Pazdur, Amna Ibrahim, Laleh Amiri-Kordestani, Julia A Beaver
U.S. FDA Drug Approvals for Breast Cancer - A Decade in Review. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Shaily Arora, Preeti Narayan, Gwynn Ison, Tara Berman, Daniel L Suzman, Suparna Wedam, Tatiana M Prowell, Soma Ghosh, Reena Philip, Christy L Osgood, Jennifer J Gao, Mirat Shah, Danielle Krol, Sakar Wahby, Melanie E Royce, Christina Brus, Erik W Bloomquist, Mallorie H Fiero, Shenghui Tang, Richard Pazdur, Amna Ibrahim, Laleh Amiri-Kordestani, Julia A Beaver
U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in Review. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Caitriona Cahir, Fengmin Zhao, Kathy D Miller, Min-Jung Lee, Richard L Piekarz, Karen Lisa Smith, Ursa A Brown-Glaberman, Jennifer S Winn, Bryan A Faller, Adedayo A Onitilo, Mark E Burkard, George T Budd, Ellis G Levine, Melanie E Royce, Peter A Kaufman, Alexandra Thomas, Jane B Trepel, Antonio C Wolff, Joseph A Sparano
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (28) (2021)
Cindy K Blair, Charles L Wiggins, Andrea M Nibbe, Curt B Storlie, Eric R Prossnitz, Melanie E Royce, Lesley C Lomo, Deirdre A Hill
Obesity and survival among a cohort of breast cancer patients is partially mediated by tumor characteristics. NPJ breast cancer 5 (2019)
Deirdre A Hill, Eric R Prossnitz, Melanie E Royce, Andrea Nibbe
Temporal trends in breast cancer survival by race and ethnicity: A population-based cohort study. PloS one 14 (10) (2019)
Sarah Friend, Melanie E Royce
The Changing Landscape of Breast Cancer: How Biology Drives Therapy. Medicines (Basel, Switzerland) 3 (1) (2016)